SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cistron Biotechnology(CIST)$.30 -- Ignore unavailable to you. Want to Upgrade?

To: Steve Harmon who wrote (1371)8/27/1998 1:19:00 PM
From: Zvi Yammer  Read Replies (3) | Respond to of 2742
 
I think the point is that if PMC is buying stock at current book value then they are valuing the technology at 0.

In other words this whole PMC deal is a fiasco,

What benifit is it to CIST to sell the stock if they need to issue warrants.

If the technology has value and PMC wishes to buy stock let them buy as much as they want in the open mkt.

If they want to invest in a company that does not need cash then they should be paying up.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News